Atıf Formatları
Evaluating leflunomide and methotrexate combination vs. monotherapy in rheumatoid and psoriatic arthritis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. Kara Et Al. , "Evaluating leflunomide and methotrexate combination vs. monotherapy in rheumatoid and psoriatic arthritis," Turkish Journal of Medical Sciences , vol.55, no.3, pp.632-643, 2025

Kara, M. Et Al. 2025. Evaluating leflunomide and methotrexate combination vs. monotherapy in rheumatoid and psoriatic arthritis. Turkish Journal of Medical Sciences , vol.55, no.3 , 632-643.

Kara, M., Alp, G., Pekdiker, M., Ketenci, S., Porreca, A., & Cinakli, H., (2025). Evaluating leflunomide and methotrexate combination vs. monotherapy in rheumatoid and psoriatic arthritis. Turkish Journal of Medical Sciences , vol.55, no.3, 632-643.

Kara, Mete Et Al. "Evaluating leflunomide and methotrexate combination vs. monotherapy in rheumatoid and psoriatic arthritis," Turkish Journal of Medical Sciences , vol.55, no.3, 632-643, 2025

Kara, Mete Et Al. "Evaluating leflunomide and methotrexate combination vs. monotherapy in rheumatoid and psoriatic arthritis." Turkish Journal of Medical Sciences , vol.55, no.3, pp.632-643, 2025

Kara, M. Et Al. (2025) . "Evaluating leflunomide and methotrexate combination vs. monotherapy in rheumatoid and psoriatic arthritis." Turkish Journal of Medical Sciences , vol.55, no.3, pp.632-643.

@article{article, author={Mete Kara Et Al. }, title={Evaluating leflunomide and methotrexate combination vs. monotherapy in rheumatoid and psoriatic arthritis}, journal={Turkish Journal of Medical Sciences}, year=2025, pages={632-643} }